Advertisement Itamar Medical names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Itamar Medical names new CEO

Itamar Medical, a medical technology company, has appointed Dov Rubin as its new CEO. Dr Rubin will be following Israel Schreiber.

Prior to joining Itamar Medical Dr Rubin was co-founder, vice president and general manager of NDS, a high tech subsidiary of Rupert Murodch’s News Corporation where he oversaw sales in the US.

Dr Rubin holds a PhD in biomedical engineering from the University of Southern California.

Giora Yaron, co-chairman of Itamar Medical, said: “Israel has led the company through the initial commercialization phase and entered into strategic collaboration with leading medical institutions and pharma companies around the world. Dov brings with him a wealth of sales and marketing experience and is best positioned to take Itamar Medical through its next sales growth phase. The board and I look forward to working closely with him through this exciting period.”